Loading…
Sanara MedTech Inc. is projected to rise to $42.32 by 2027, a +25% move from its current price of $33.86. SMTI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $32.66 | $33.91 | $35.21 | +0.14% |
| Aug 4 | $32.19 | $33.95 | $35.81 | +0.27% |
| Aug 5 | $31.86 | $34.00 | $36.29 | +0.41% |
| Aug 6 | $31.58 | $34.05 | $36.71 | +0.55% |
| Aug 7 | $31.34 | $34.09 | $37.08 | +0.69% |
| Aug 8 | $31.14 | $34.14 | $37.43 | +0.83% |
| Aug 9 | $30.95 | $34.19 | $37.76 | +0.96% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $30.95 | $34.19 | $37.76 | +0.96% |
| Week 2 | $29.99 | $34.52 | $39.73 | +1.94% |
| Week 3 | $29.33 | $34.85 | $41.40 | +2.92% |
| Week 4 | $28.84 | $35.19 | $42.93 | +3.92% |
| Week 5 | $28.44 | $35.53 | $44.38 | +4.92% |
| Week 6 | $28.11 | $35.87 | $45.77 | +5.93% |
| Week 7 | $27.83 | $36.21 | $47.12 | +6.95% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sanara MedTech Inc. is a medical technology company that develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company was incorporated in 2001 and is based in Fort Worth, Texas.
Its product portfolio includes CellerateRX Surgical, a hydrolysate of Type I bovine collagen for wound management; BIASURGE, a no-rinse surgical solution for wound irrigation; FORTIFY Tissue Repair Graft, a freeze-dried extracellular matrix sheet; BiFORM, an osteoconductive implant; ACTIGEN Inductive Bone Matrix, a differentiated allograft matrix; ALLOCYTE Plus, a human allograft cellular bone matrix; and TEXAGEN, a multi-layer amniotic membrane allograft. The company also holds a license agreement with Rochal to develop antimicrobial products such as BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser.
This concise description reflects the company’s focus on orthopedic, wound care, and antimicrobial surgical solutions within the healthcare sector, based in the United States.
SMTI is currently priced at $34.06 per share with a market capitalization of $313.12M. It holds a rank of 3250, placing it among smaller-cap healthcare equities.
The stock’s 30-day price range spans from $26.37 to $44.00, and technicals show a bullish tilt with an RSI of 80. The stock is trading above key moving averages, with a SMA50 of $23.83 and a SMA200 of $22.40. Near-term support sits at $21.22 and resistance at $34.06, framing a constructive setup as price action navigates the recent range.
Looking ahead, the multi-year forecast envisions upside across years, with the 2026 average price at $34.06 and substantial growth by 2030 ($95.05 average) and beyond (2040 average $259.45; 2050 average $797.86). The sentiment tilts bullish from 2027 onward, signaling meaningful upside over the coming years.
A major floor 51.7% below — a decisive break under it would weaken the trend.
The nearest floor, 35.8% below — buyers have tended to step in here.
Price is pressing into resistance (0.6% away) — a breakout level to watch.
A major ceiling 24.6% above — clearing it would confirm fresh momentum.
Key SMTI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SMTI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $30.13 | Buy | $31.01 | Buy |
| MA 10 | $27.78 | Buy | $28.86 | Buy |
| MA 20 | $26.14 | Buy | $26.92 | Buy |
| MA 50 | $24.06 | Buy | $24.51 | Buy |
| MA 100 | $21.49 | Buy | $23.17 | Buy |
| MA 200 | $22.42 | Buy | $23.62 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 83.03 | Sell |
| Stoch RSI (14) | 95.99 | Sell |
| CCI (20) | 254.22 | Buy |
| Williams %R (14) | -1.89 | Info |
| MACD (12,26,9) | 0.88 | Buy |
| ROC (12) | 38.04 | Buy |
| Bollinger %B (20,2) | 1.16 | Sell |
| Stochastic %K (14) | 98.11 | Sell |
| TRIX (15) | 0.71 | Buy |
| Awesome (5,34) | 5.36 | Buy |
| Ultimate (7,14,28) | 90.99 | Sell |
| Momentum (10) | 8.86 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 33.47 | Buy |
| ADX (14) | 27.25 | Buy |
| ATR (14) | 0.90 | Info |
The 30-day technical picture is bullish, with RSI14 at 80 signaling strong momentum in the near term.
Price action sits above the SMA50 of $23.83 and the SMA200 of $22.40, reinforcing a constructive near-term trajectory. The immediate support level is $21.22, while resistance stands at $34.06, delineating a defined range in the short run.
The 30-day price range runs from $26.37 to $44.00, illustrating volatility but with a bullish bias under current conditions.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.34 | $33.86 | $52.11 | 0% | Neutral | |
| $32.60 | $42.32 | $58.74 | +25% | Bullish | |
| $37.63 | $50.87 | $74.16 | +50% | Bullish | |
| $54.74 | $76.56 | $115.92 | +126% | Bullish | |
| $65.60 | $94.55 | $147.75 | +179% | Bullish | |
| $72.61 | $107.58 | $172.77 | +218% | Bullish | |
| $77.23 | $117.43 | $193.23 | +247% | Bullish | |
| $81.21 | $126.56 | $212.86 | +274% | Bullish | |
| $89.23 | $142.36 | $244.29 | +320% | Bullish | |
| $102.89 | $167.91 | $293.52 | +396% | Bullish | |
| $143.13 | $259.45 | $489.75 | +666% | Bullish | |
| $361.24 | $792.68 | $1,670.11 | +22.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $16.34 | $33.86 | $43.59 | +0.00% |
| September 2026 | $31.98 | $38.25 | $47.33 | +12.95% |
| October 2026 | $31.78 | $38.37 | $48.18 | +0.33% |
| November 2026 | $31.79 | $38.69 | $49.14 | +0.81% |
| December 2026 | $33.13 | $40.60 | $52.11 | +4.95% |
Click any year to see its month-by-month SMTI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, SMTI is projected to trade between $16.34 and $52.11, averaging $33.86 — a potential gain of 0% from today's $33.86. Price action looks broadly range-bound.
Sanara MedTech Inc.'s 2027 outlook centres on $42.32, within a $32.60 to $58.74 range. That is up +25% on the projected 2026 average. That marks a +25% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, SMTI could reach as high as $74.16, with a base case around $50.87 and support toward $37.63 — roughly +50% from $33.86. Momentum favours further upside here.
Expect SMTI to range from $54.74 to $115.92 through 2029. The $76.56 average target implies a +126% move from current prices. That is up +51% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The SMTI price prediction for 2030 points to an average of $94.55 (low $65.60, high $147.75) — a potential gain of +179% on today's $33.86. Momentum favours further upside here.
In 2031, SMTI is projected to trade between $72.61 and $172.77, averaging $107.58 — a potential gain of +218% from today's $33.86. That is up +14% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Sanara MedTech Inc.'s 2032 outlook centres on $117.43, within a $77.23 to $193.23 range. That is up +9% on the projected 2031 average. That marks a +247% change versus current levels. Momentum favours further upside here.
By 2033, SMTI could reach as high as $212.86, with a base case around $126.56 and support toward $81.21 — roughly +274% from $33.86. Buyers look set to stay in control over this stretch.
Expect SMTI to range from $89.23 to $244.29 through 2034. The $142.36 average target implies a +320% move from current prices. That is up +12% on the projected 2033 average. Momentum favours further upside here.
The SMTI price prediction for 2035 points to an average of $167.91 (low $102.89, high $293.52) — a potential gain of +396% on today's $33.86. Buyers look set to stay in control over this stretch.
In 2040, SMTI is projected to trade between $143.13 and $489.75, averaging $259.45 — a potential gain of +666% from today's $33.86. That is up +55% on the projected 2035 average. Momentum favours further upside here.
Sanara MedTech Inc.'s 2050 outlook centres on $792.68, within a $361.24 to $1,670.11 range. That is up +206% on the projected 2040 average. That marks a +22.4x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in SMTI today (≈ 29.533373 SMTI) could be worth
$23,410.41
+$22,410.41 (+2241%) by 2050 · US Dollar
Based on the average projected SMTI price of $792.68 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SMTIwould be worth at today's price.
$1,000 invested in SMTI on Jul 31, 2025 (≈ 41.373604 SMTI) would be worth
$1,400.91
+$400.91 (+40.1%) today · 1.40× · US Dollar
Based on a SMTI entry price of $24.17 vs. today's $33.86.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $25.56 | $1,324.73 | +32.5% |
| 1 month ago | $24.27 | $1,395.14 | +39.5% |
| 3 months ago | $19.73 | $1,716.17 | +71.6% |
| 6 months ago | $22.05 | $1,535.6 | +53.6% |
| 1 year ago | $24.17 | $1,400.91 | +40.1% |
| All time (5.0y) ago | $38.8 | $872.68 | -12.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SMTI forecast.
Our base-case forecast reaches $68.00 around 2029.
Implied market cap at $68.00: $625.13M
The year-by-year forecast shows mixed near-term dynamics and clear longer-term upside. For 2026, the average price is $34.06 with a min of $16.34 and a max of $52.88, yielding a 0% ROI and a Neutral sentiment.
From 2027 onward, the outlook turns clearly bullish, with 2027 average $42.28 (ROI 24.1%), 2028 average $50.96 (ROI 49.6%), and 2029 average $77.42 (ROI 127.3%). By 2030, the average is $95.05 with a min of $65.39 and max of $149.81, and ROI of 179.1%.
The forecast continues rising through 2031–2035, with 2031 average $108.31 (ROI 218%), 2032 average $118.40 (ROI 247.6%), 2033 average $126.44 (ROI 271.2%), 2034 average $142.55 (ROI 318.5%), and 2035 average $168.54 (ROI 394.8%). In 2040, the average reaches $259.45 (ROI 661.7%), and by 2050 the average is $797.86 (ROI 2242.5%). All years shown carry bullish sentiment.
These figures are estimates and not guarantees; actual results may vary. The trajectory suggests meaningful upside over the coming years, but uncertainty remains inherent in long-horizon forecasts.
Tap a question to reveal the answer.
The average forecast price in 2030 is $95.05, with a min of $65.39 and a max of $149.81; ROI: 179.1%.
Forecasts show bullish sentiment in 2027 through 2050, with expanding average prices and positive ROI (e.g., 2027 avg $42.28, ROI 24.1%; 2030 avg $95.05, ROI 179.1%), though 2026 is neutral.
Yes. The forecast indicates averages above $100 starting in 2031 ($108.31) and 2032 ($118.40), with 2030 averaging $95.05.
The 30-day price range is $26.37 to $44.00.
The current price is $34.06 and market capitalization is $313.12M.
Sanara MedTech Inc. Community Discussion
0Share your Sanara MedTech Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.